Eric Vaillancourt, Alaa Afdal Mohamed, Jay Ansell, Takao Ashikaga, Ahmed Ayad, Hadeel Ayman, Marize Valadares Campos, Han-Sheng Chien, Arianna Giusti, Masato Hatao, Frances Hill, Abeer Khattab, Reinhard Kreiling, Ah Young Lee, Miao Li, Pinpin Lin, Yen-Chun Lin, Victor Mencarelli, Stanley Milstein, Beta P Montemayor, Carolina Motter Catarino, Rawda Negm, Gladys Ouédraogo, Eun Jae Park, Mustafa Varçin, Tzu-Yi Yang, Yu Janet Zang, Matthew Philip Dent
{"title":"Highlighting best practices to advance next-generation risk assessment of cosmetic ingredients.","authors":"Eric Vaillancourt, Alaa Afdal Mohamed, Jay Ansell, Takao Ashikaga, Ahmed Ayad, Hadeel Ayman, Marize Valadares Campos, Han-Sheng Chien, Arianna Giusti, Masato Hatao, Frances Hill, Abeer Khattab, Reinhard Kreiling, Ah Young Lee, Miao Li, Pinpin Lin, Yen-Chun Lin, Victor Mencarelli, Stanley Milstein, Beta P Montemayor, Carolina Motter Catarino, Rawda Negm, Gladys Ouédraogo, Eun Jae Park, Mustafa Varçin, Tzu-Yi Yang, Yu Janet Zang, Matthew Philip Dent","doi":"10.1016/j.namjnl.2025.100020","DOIUrl":null,"url":null,"abstract":"<p><p>Public expectations and regulatory demands have driven a paradigm shift in cosmetic ingredient safety assessment. Next-generation risk assessment (NGRA) and new approach methodologies (NAMs) provide an opportunity to implement alternative procedures which are more ethical and biologically-relevant, have the potential to become more cost-effective and time-efficient, and are at least as protective of human health as traditional, animal-based approaches. However, the sheer number and diversity of the rapidly-evolving NAMs currently available can be confusing and overwhelming to safety assessors. To successfully transition from principles to routine application, NAMs must gain acceptance within safety assessment communities. Harmonizing NAMs and establishing standardized risk assessment workflows are paramount to gaining regulatory acceptance. Consequently, the International Cooperation on Cosmetics Regulation (ICCR) has tasked a team of scientists from regulatory authorities and the cosmetic industry to define best practices which align with the ICCR principles of NGRA for cosmetic ingredients, to help advance the acceptance and use of NAMs in cosmetic safety assessment and, where applicable, regulatory decision-making.</p>","PeriodicalId":520522,"journal":{"name":"NAM journal","volume":"1 ","pages":"100020"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13288993/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NAM journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.namjnl.2025.100020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Public expectations and regulatory demands have driven a paradigm shift in cosmetic ingredient safety assessment. Next-generation risk assessment (NGRA) and new approach methodologies (NAMs) provide an opportunity to implement alternative procedures which are more ethical and biologically-relevant, have the potential to become more cost-effective and time-efficient, and are at least as protective of human health as traditional, animal-based approaches. However, the sheer number and diversity of the rapidly-evolving NAMs currently available can be confusing and overwhelming to safety assessors. To successfully transition from principles to routine application, NAMs must gain acceptance within safety assessment communities. Harmonizing NAMs and establishing standardized risk assessment workflows are paramount to gaining regulatory acceptance. Consequently, the International Cooperation on Cosmetics Regulation (ICCR) has tasked a team of scientists from regulatory authorities and the cosmetic industry to define best practices which align with the ICCR principles of NGRA for cosmetic ingredients, to help advance the acceptance and use of NAMs in cosmetic safety assessment and, where applicable, regulatory decision-making.